The Healthcare Technology Report is pleased to announce The Top 50 Women Leaders in Healthcare Technology of 2024. In a rapidly changing and evolving industry, these executives are helping chart a course for an industry that is projected to hit $1 trillion within the next 10 years.
The awardees on this year’s list represent some of the most innovative companies in the healthcare technology space. They provide their organizations with steady leadership and deep knowledge in their respective specialties, piloting their companies through ever-changing market conditions with an unwavering focus on customer needs, in different ways.
Kyoko Deguchi, our No.1 executive, has been a trailblazer at PHC Group since taking over as CEO in April 2024, launching an updated vision and Value Creation Plan to help steward PHC into the future; Dr. Anne Snowdon, the Chief Scientific Research Officer at HIMSS, has published more than 150 papers and articles in the healthcare technology field; Jzaneen “J-z” Lalani, Chief Business Officer of Nusano, has done breakthrough work with radioisotopes, while Dornoosh Zonoobi, VP of AI at Exo Imaging, is helping the industry adapt to the technological breakthrough driving innovation across industries.
Please join us in celebrating The Top 50 Women Leaders in Healthcare Technology of 2024.
1. Kyoko Deguchi
Firm: PHC Group
Title: President, Representative Director, and CEO
Kyoko (Kay) Deguchi is the Chief Executive Officer of PHC Holdings Corporation, a global collection of healthcare businesses referred to collectively as PHC Group. Together, PHC Group companies are focused on precision technology that powers the future of healthcare. PHC Group companies and brands include Ascensia (diabetes management), Epredia (cancer diagnostic solutions), PHCbi (cell preservation and growth), PHC IVD (in vitro diagnostics), Wemex (healthcare IT), LSI Medience (clinical testing), and Mediford (drug development).
Deguchi joined PHC Group as an independent external board director in 2021, bringing more than two decades of experience as a business leader, including in the healthcare industry. She became CEO in April 2024, and in her first six months launched an updated vision and value creation plan outlining PHC Group’s new global strategy to focus future growth on diagnostics and life sciences.
In that time, Deguchi also met with more than 500 employees at roundtables across PHC Group’s subsidiaries to discuss how the company can collectively make a greater impact on health through precision technology.
As PHC Group’s first female CEO, Deguchi is a modern leader for an increasingly diverse company and industry. She prioritizes inclusion and is a vocal proponent of the concept of “One PHC,” a company mindset that seeks to create synergies across divisions and disciplines to create greater value for researchers, healthcare providers, and the patients they serve.
2. Suset Silva
Firm: LifeLabs
Title: VP, Culture, Communications & Engagement
Suset Silva plays a vital role in shaping the identity and voice of LifeLabs Medical Laboratories, leading its efforts in culture, communications, and engagement. A strategic and visionary leader, Silva drives cross-Canada initiatives through communication strategies, media relations, and authentic stakeholder engagement.
Silva is a champion for projects that prioritize inclusivity and diversity and is a steward of LifeLabs’ ‘Stronger Together’ Diversity, Equity, and Inclusion (DEI) Program. Her commitment to creating an empowering environment has not only enhanced company culture but has also significantly strengthened LifeLabs’ relationship within its communities.
Silva has a comprehensive understanding of the LifeLabs organization and serves as a key strategic advisor, providing insight and solutions. She has led communications during numerous pivotal moments for LifeLabs, focusing on delivering strategic, transparent, and well-executed messaging. As a values-based leader, she is driven by her connection to purpose, excellence, authenticity, and integrity shaping her service leadership philosophy of building and coaching high-performing, engaged teams.
With a distinguished career in healthcare communications that spans over two decades, Silva has made an indelible impact on the industry. Her industry contributions include volunteering for the International Association of Business Communicators (IABC) as a mentor to future communicators and award nomination review committee for the Gold Quill Award of Communication Excellence.
She holds a bachelor’s degree in professional communication from Royal Roads University and is a graduate of the University of Toronto Rotman School of Management’s Women’s Executive Leadership – The Judy Project and Healthcare Leadership programs.
3. Chitra Kotwaliwale
Firm: Natera
Title: SVP Clinical & Commercial Operations, Portfolio Management
Chitra Kotwaliwale serves as Senior Vice President of Clinical and Commercial Operations and Portfolio Management. She joined Natera in 2019 and has held multiple roles across product management and strategy, overseeing product management for the women’s health team, managing overall strategic planning and PMO for Engineering/R&D, and coordinating global product strategy.
Prior to joining Natera, Kotwaliwale served as director of product marketing at Agilent Technologies, where she managed the company’s product management team responsible for target enrichment content products for rare diseases and oncology. She previously served as senior product manager of sequencing at Complete Genomics, and prior to that, as a computational biologist at Adaptive Biotechnologies (formerly Squenta).
Kotwaliwale holds a bachelor’s degree in biology from the College of Wooster and a Ph.D. in molecular and cell biology from the University of Washington and the Fred Hutchinson Cancer Center. She completed her postdoctoral fellowships at the University of California, Berkeley.
4. Nish Parekh
Firm: Omnicell
Title: Senior Vice President, Chief Product Officer
Nish Parekh re-joined Omnicell in June 2023 as Senior Vice President and Chief Product Officer. With a proven track record in leading global product management organizations, she brings a wealth of experience and a passion for creating customer-centric solutions. As leader of Omnicell’s global product management organization and North American marketing, Parekh drives innovation across product and services development, design, program management, marketing intelligence, and business development.
Following product leadership roles at AppliedVR, Omnicell, IBM Watson Health, and Epic Systems, she has a deep understanding of delivering end-to-end product experiences that solve meaningful problems and delight customers. Parekh graduated from Emory University at the Goizueta Business School with a degree in finance.
5. Carla da Luz Boren
Firm: Corza Medical
Title: Chief Human Resources Officer
Carla da Luz Boren is the Chief Human Resource Officer of Corza Medical. She brings more than 20 years of deep experience leading HR strategy, execution, people and teams for global, growth-oriented public and private companies in the life sciences and medical device industries.
Prior to joining Corza Medical in 2021, Boren served in several senior leadership roles, most recently as General Counsel and Chief Human Resources Officer at Otonomy. She also held various global senior leadership positions at Life Technologies/Thermo Fisher, where she excelled as Vice President of Human Resources. Earlier in her career, Boren practiced law at prominent firms including DLA Piper and Littler Mendelson.
Boren holds a bachelor’s degree in political economy of industrial societies from the University of California, Berkeley, and a JD from the University of California, Los Angeles.
6. Moliehi Weitnauer
Firm: MRO
Title: Chief Product Officer
As Chief Product Officer, Moliehi Weitnauer drives the product strategy and roadmap for MRO. MRO is accelerating the exchange of clinical data throughout the healthcare ecosystem on behalf of providers, payers, and users of clinical data. By utilizing industry-leading solutions and incorporating the latest technology, MRO facilitates the efficient management and exchange of clinical data for all stakeholders.
Weitnauer has proven to be a visionary leader, consistently shaping the direction of MRO’s product portfolio and overall business strategy. Her ability to anticipate market shifts and translate those insights into actionable plans has been a cornerstone of MRO’s growth since she joined the organization in January 2023.
Whether developing new products or enhancing existing ones, Weitnauer ensures that each initiative aligns with both short-term objectives and MRO’s long-term strategic goals. Her talent for crafting comprehensive business strategies has resulted in highly successful product launches, driving both innovation and profitability across the organization.
Before coming to MRO, Weitnauer was the SVP of Corporate and Product Strategy at Cotiviti, a healthcare company helping healthcare payers manage medical costs and advance care quality. Prior to Cotiviti, Weitnauer was at FinThrive, a provider-focused company, where she led product management for its portfolio of billing and denials management technology solutions.
Weitnauer spent the earlier part of her career as a management consultant at McKinsey & Company and The Bridgespan Group. She graduated with a bachelor’s degree in biochemistry and economics from Smith College and got her master’s degree in health policy and management from Harvard T.H. Chan School of Public Health.
7. Ginny Blocki
Firm: Embecta
Title: SVP, Global Marketing and Product Management
Ginny Blocki serves as the SVP, Global Marketing and Product Management of embecta, where she helped lead the business through a spinoff into an independent, publicly traded company. Since the spinoff, Blocki has been an integral part of the leadership team, focusing on corporate priorities including developing and executing a new corporate brand, leading and sponsoring key programs, initiating strategic product identification, launch and rebranding efforts, and standing up a global marketing organization.
Prior to her work at embecta, Blocki held key executive roles with Baxter, Assertio Therapeutics, Abbott Laboratories, Baxalta (a spinoff from Baxter), and Takeda, where she played a vital role in driving results through innovative strategies, strong execution, and high performing teams.
Throughout her career, Blocki has held leadership roles of increasing responsibility in general management, marketing, strategy, market access, and sales. She has a proven track record of building successful businesses and developing strong brands through different phases of product development, working with cross-functional teams on a regional, national, and global scale.
Blocki holds a bachelor’s degree in finance from Indiana University. She’s also a Kellogg School of Management alum having completed the Executive Scholar Program in general management.
8. Anna Lucsok
Firm: Zynex Medical
Title: Chief Operating Officer
Anna Lucsok is the Chief Operating Officer of Zynex Medical. Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company’s proprietary NeuroMove device, designed to help recovery of stroke and spinal cord injury patients.
Lucsok previously served as Vice President of Reimbursement and Sales Operations with Zynex Medical. In this position she was responsible for leading and expanding Zynex’s order, reimbursement, patient experience, and inside sales support operations. During her tenure each of these teams have consistently achieved quarterly targets, while also expanding in size. Lucsok brings more than nine years of healthcare operations experience as well as critical knowledge of revenue cycle management and medical care collections.
Lucsok has been involved in various operations positions as well as management positions with Zynex since her start in 2018, including serving as billing manager. She’s previously held key positions with companies including the University of Colorado Hospital, the U.S. Air Force in Germany and Japan, and Schryver Medical. Lucsok holds certification in medical billing and completed her degree in healthcare administration and management from Colorado State University.
9. Bevey Miner
Firm: Consensus Cloud Solutions
Title: EVP Healthcare Strategy and Policy
Bevey Miner is Executive Vice President of Healthcare Strategy and Policy for Consensus Cloud Solutions. She has been instrumental in leading healthcare strategy, product launches, business development, marketing, and commercialization for the company.
Bevey has established herself as a leading healthcare voice on tech equity, arguing that it is critical to achieving health equity. In doing so, she cemented Consensus as a global leader of digital cloud fax technology and provider of interoperability solutions, as a thought leader and partner with healthcare stakeholders in designing pragmatic solutions that benefit our most vulnerable patient populations.
Miner has spoken to leaders at the Office for the National Coordinator for Health IT (ONC), the U.S. Department of Health and Human Services, the Centers for Disease Control and Prevention (CDC), and federal legislators on digital health policy. She led Consensus’ response to the ONC on their Health Equity by Design plan, commenting on proposed strategies for modernizing systems for public health data exchange and the CDC’s Data Modernization Initiative. She has also commented on The ONC 2024-2023 Strategic Road Map, the CHAI guideline for implementing AI in healthcare, and HTI-2.
Miner has more than 20 years of experience in healthcare technology and digital health. Prior to joining Consensus, Bevey served in executive roles with companies including Allscripts, NextGen EHR, Healthloop/Getwell Networks and Ginger.io, where she was instrumental in making meaningful changes in the way healthcare technology can advance patient care, detect behavioral health issues and prevent harmful errors from occurring during workflow. Miner has been considered a healthcare luminary speaking at many conferences and as a guest on webinars.
10. Molly Henderson
Firm: Phathom Pharmaceuticals
Title: Chief Financial and Business Officer
As Chief Financial and Business Officer, Molly Henderson has been instrumental in driving Phathom’s success, including helping to raise significant capital to fuel the company’s strategic growth and further support the commercial launch of the first innovation in the U.S. for gastroesophageal reflux disease (GERD) in over three decades.
Prior to joining Phathom, Henderson was the Chief Financial Officer of UroGen Pharma, a commercial-stage biopharmaceutical company focused on building novel treatments for specialty cancers and urologic disease. She has more than 20 years of extensive experience in the pharmaceutical industry.
Ms. Henderson has also served as Chief Financial Officer and Executive Vice President of Advaxis, Inc., Chief Financial Officer of Iovance Biotherapeutics (formerly Lion Biotechnologies), and prior to that, the Chief Business and Financial Officer and Senior Vice President of VirtualScopics. Additionally, she served as a member of the board of directors and chair of the audit committee of Calliditas Therapeutics AB.
Ms. Henderson earned her MBA and master’s degree in accounting from the State University of New York at Buffalo.
11. Casandra Mangroo
Firm: BenchSci
Title: Senior Vice President of Product and Science
As SVP of Product and Science at BenchSci, Casandra Mangroo has been instrumental in developing the company’s product vision to accelerate preclinical drug discovery by empowering scientists in leading research laboratories with cutting-edge deep learning technology through BenchSci’s ASCEND platform.
Mangroo leads BenchSci’s science and product teams, which are focused on helping research scientists perform due diligence and execute successful experiments to accelerate the pace of therapeutic discoveries in preclinical drug discovery. She works closely with executive leadership and scientists across top pharmaceutical companies to translate organizational research challenges into impactful solutions. In collaboration with technical, scientific and commercial teams, she defines platform strategy through data, ML, and product initiatives.
Mangroo is equally passionate about diversity in STEM. As the executive sponsor of BenchSci’s first ERG, BenchShe+, she mentors and empowers women leaders in tech.
12. Marina Dorotheo
Firm: Welldoc
Title: Chief Marketing and Strategy Officer
As Chief Marketing and Strategy Officer, Marina Dorotheo oversees Welldoc’s corporate, marketing and communications strategy driving the company’s brand, partnerships across healthcare organizations, as well as awareness, education and engagement with consumers and healthcare professionals.
With more than a decade of experience at the forefront of digital health, Dorotheo has been instrumental in transforming innovative ideas into tangible solutions that improve patient outcomes. At Welldoc, she has played a pivotal role in evolving the company’s platform and capabilities, from an FDA-approved singularly focused on diabetes to a comprehensive multi-condition platform across cardiometabolic conditions.
Prior to Welldoc, Dorotheo worked at Otsuka Pharmaceuticals, where she led digital health innovations focused on severe mental illness. Dorotheo received a bachelor’s degree in biochemistry from Georgia Tech and a master’s degree in biotechnology from Johns Hopkins University. Given her expertise in mental health, she currently serves as a board member of the nonprofit organization Schizophrenia and Psychosis Action Alliance.
13. Lee Ann Fachko
Firm: Burlington Medical
Title: Chief Executive Officer
After spending a decade leading Beekley Medical Corporation’s sales organization, Lee Ann Fachko joined Burlington Medical as Senior Vice President of Global Sales and Marketing, rising to CEO within four years. As Senior VP, Fachko fostered a profound sense of purpose among Burlington’s employees, highlighting their role as artisans creating lifesaving radiation protection garments.
Later, as CEO, she strategically propelled the company’s growth by acquiring two key competitors, fortifying Burlington’s place in the industry. Burlington Medical is a leading global provider of radiation protection solutions, committed to developing innovative products that serve and protect healthcare professionals who save lives.
With more than 25 years of experience in the medical device and biotech industries, Fachko continues to shape Burlington’s future, reinforcing the company’s commitment to innovation and positioning it as a vertically integrated global leader in the radiation protection industry. Fachko graduated from the State University of New York at Fredonia with an undergraduate degree in accounting.
14. Dr. Anne Snowdon
Firm: HIMSS
Title: Chief Scientific Research Officer
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor, in Ontario, Canada. Dr. Snowdon is also the Chief Scientific Research Officer for HIMSS, currently a well-established program of research focused on digital health, digitally enabled supply chain capacity to deliver safe and equitable care to patients, strengthening economic value and health system performance for global health systems.
Currently, Dr. Snowdon is a member of the Ontario Research Fund Advisory Board, an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark.
Dr. Snowdon has published more than 150 research articles, papers and cases, has received over $25 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles, and is a Fulbright Scholar. She holds a Ph.D. in nursing from the University of Michigan, a master’s degree from McGill University, and a bachelor’s degree from Western University.
15. Dr. Ye Zhang
Firm: Arcturus Therapeutics
Title: Chief Regulatory Officer
Dr. Ye Zhang is the Chief Regulatory Officer for Arcturus Therapeutics, where she established the Regulatory Affairs department and oversees regulatory strategy, regulatory CMC, regulatory operation and labeling to support the development of vaccines and rare disease therapeutics. Arcturus is a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases.
Arcturus has the proprietary lipid nanoparticle delivery system (LUNAR), as well as the proprietary Self-Transcribing and Replicating RNA technology (STARR). Arcturus developed KOSTAIVE, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to receive approval.
Dr. Zhang has more than 20 years of experience in regulatory and drug development for vaccines, biologics and small molecules. Prior to joining Arcturus Therapeutics, Dr. Zhang held various roles of increasing responsibility at Merck, where she was responsible for more than 10 vaccines in development and life-cycle management and had extensive experience in working with FDA, EMA, PMDA, MHRA, NMPA, TGA, and other regulatory authorities. She also worked at the FDA, where she reviewed more than 60 drug applications and gained extensive regulatory experience.
Dr. Zhang received a Ph.D. in pharmaceutical sciences from the University of Colorado, and an MD from the Medical School of Peking University. Dr. Zhang is a lifetime member of the Food and Drug Administration Alumni Association (FDAAA) and serves as a board director for Alliance for mRNA Medicine (AMM).
16. Lisa Morella
Firm: CodaMetrix
Title: SVP of Data and Analytics
Lisa Morella, MBA, is CodaMetrix’s SVP of Analytics and Data Governance, leading data lakehouse, integration and business teams. With more than 15 years at Mass General Brigham (MGB), she spearheaded enterprise-wide data platform initiatives and drove a 400 percent increase in Tableau platform adoption. With extensive experience in data governance, security, and analytics, Morella has been instrumental in aligning CodaMetrix’s AI/ML capabilities to meet the complex needs of healthcare organizations and transform their revenue cycles.
17. Angela Cromer
Firm: Angle Health
Title: Head of Health Plan Operations
Angela Cromer is a seasoned senior executive with more than 25 years of experience in health insurance. Driven by a passion for advancing technology in healthcare, Cromer joined Angle Health, an AI-enabled, member- and patient-centric healthcare company democratizing access to modern healthcare services through its custom, full-service health plans for employers. Cromer serves as Head of Health Plan Operations at Angle Health and President and General Manager of its third-party administrator (TPA) entity.
Cromer is a results-driven leader who takes extreme ownership in transforming underperforming processes and teams into high-functioning, efficient, and self-sustaining units. With deep expertise in operational processes and relationship management, she aims to simplify the complexities of health insurance. By uniting engineering and business leaders, her teams have increased productivity by over 150 percent and eliminated numerous manual and inefficient processes.
Cromer has also led direct-to-employer initiatives with major hospital systems nationwide. She is deeply committed to helping and mentoring others, crediting her early customer service experience for shaping her understanding of healthcare’s complexities and for developing her into the dedicated professional she is today.
18. Karen Tubridy
Firm: Abcuro
Title: Chief Operating Officer
Karen Tubridy is the Chief Operating Officer of Abcuro. She brings more than 30 years of experience in drug development strategy and operations supporting novel and first-in-class therapeutics. Previously, Karen served as a Chief Development Officer at Verseau Therapeutics, Akebia Therapeutics, and Eleven Bio. She has had responsibility for driving global program strategies to IND, NDA and J-NDA filings
In addition, she has had responsibility for oversight of drug development operations including the build out of core R&D infrastructure and quality systems. Previously, she held senior positions in clinical and regulatory operations at Inspiration Biopharmaceuticals, Taligen Therapeutics (acquired by Alexion) and Syntonix Pharmaceuticals (acquired by Biogen). She held a senior position at AVANT Immunotherapeutics directing several vaccine programs and held positions of increasing responsibility in clinical research and medical affairs at Genetics Institute/Wyeth Pharmaceuticals, where she directed hematology and oncology programs. Karen holds a B.S. in pharmacy and a PharmD from the Massachusetts College of Pharmacy and Allied Health Sciences.
19. Sheila Bailey
Firm: Vizzia Technologies
Title: CFO
Sheila Bailey has led the financial strategy and operations of Vizzia Technologies as Chief Financial Officer for the past six years. In 2024, Vizzia was acquired by HID Corporation, a subsidiary of the $13 billion Assa Abloy Group.
Bailey has more than 30 years of financial and operational leadership for high growth technology companies. She served as Vice President of Finance for Luma, a Wi-Fi solutions startup. Luma raised $22 million from Amazon, Google and Andreessen Horowitz, and was acquired by Newell Brands. Bailey was Chief Compliance Officer and Vice President of Finance for Rubicon Technologies, a venture-backed technology company.
Additionally, she has held several financial leadership positions at Gypsum Management & Supply, leading up to its $147 million IPO. Bailey received her MBA from Georgia State University and a bachelor’s degree from Emory University. She also studied at Harvard University and the University of London.
19. Lisa Bond Brewer
Firm: UST HealthProof
Title: Chief Communications Officer
An accomplished communications strategist, Lisa Bond Brewer leads communications initiatives at UST HealthProof, where she guides the company’s messaging and builds its reputation.
In 2024, Brewer led UST HealthProof through a successful rebrand and website launch. Working closely with the marketing team, she ensured both initiatives effectively showcased the company’s evolution. The rebrand reflected UST HealthProof’s growth from a service provider to an industry leader in healthcare technology solutions. Her team developed clear messaging that resonated with clients while maintaining the trusted relationships built under the previous brand.
Brewer brings 30 years of leadership experience in education, finance, and healthcare to her role. Her expertise spans change management, diversity, equity, and inclusion (DEI), corporate reputation, branding, issues management, and internal communications.
As UST HealthProof’s communications leader, Brewer directs strategic messaging that helps the company navigate complex challenges and connect with its audiences effectively.
20. Ali Morin
Firm: symplr
Title: Chief Nursing Informatics Officer
Ali Morin is the Chief Nursing Informatics Officer of Symplr. As a board-certified clinical informatics nurse with more than 20 years of direct and operational healthcare IT experience, Morin is a leader in strategic and operational nursing communication and technology-enabled care delivery.
Morin has extensive experience with adopting process change to maximize patient safety, quality of care, and operational efficiency. She has led the development, deployment, re-engineering, optimization, and integration of clinical information systems and is well-versed in ensuring continuous clinical regulatory readiness.
Externally, Morin represents symplr on the Healthcare Information and Management Systems Society (HIMSS) Vendor CNO/CNIO working group, the Alliance for Nursing Informatics (ANI) Policy Committee, and is co-leader of the American Organization for Nursing Leadership (AONL) Digital Transformation Competency Workgroup. As part of her work with AONL, Morin helped develop new guiding principles that ensure nurse leaders are equipped with the necessary skills to support and lead digital health strategies and transformations.
20. Brie Solitario
Firm: PartsSource
Title: Director of Service Operations
Brie Solitario, Director of Service Operations at PartsSource, has a distinguished career marked by strong leadership, a deep technical foundation, and a focus on continuous improvement in service of customers. Since joining PartsSource in February 2020, Brie has played a key role in launching and scaling the company’s On-Demand Service and Depot Service business, driving growth from a team of two to a successful operation serving thousands of customers.
Solitario has consistently refined On-Demand Service offerings and overseen substantial improvements in customer communication, turnaround times, and service quality. Her ability to leverage technology to streamline operations through advancements in Salesforce and PartsSource.com, has been instrumental in the company’s success.
Solitario holds several certifications that complement her technical expertise and leadership capabilities. She is a Certified Lean Six Sigma Black Belt from Kent State University, a graduate of the Value-Based Leadership Program at Zimmer Biomet, and an alumna of Ohio University’s Leadership Development Program. Additionally, she is certified in AAMI Quality System Requirements and AAMI Process Validation Requirements and Industry Practice.
Before her role at PartsSource, Solitario held various leadership positions at Zimmer Biomet Surgical, where she honed her skills in operations management, engineering, and continuous improvement.
With an MBA in executive management from Ohio University and a bachelor’s degree in biomedical engineering from The University of Akron, Solitario’s career is a testament to her unique combination of technical expertise, leadership skills, and commitment to continuous improvement. Her comprehensive background in operations, engineering, and leadership has positioned her as a key figure in the growth and success of PartsSource’s service operations.
21. Dr. Tina Hunt
Firm: IDEXX Laboratories
Title: Executive Vice President, Global Strategy and Commercial
Dr. Tina Hunt is an accomplished executive with a distinguished record of leadership in the healthcare technology industry. As Executive Vice President of Global Strategy and Commercial at IDEXX Laboratories, a leader in pet healthcare diagnostics and software, Dr. Hunt drives the company’s strategic vision while overseeing global commercial operations, marketing, medical affairs, and business development. Her leadership has been pivotal in delivering innovative diagnostic solutions that help elevate the standard of care in veterinary medicine and create new global business opportunities.
Recognized for her strategic acumen and results-driven approach, Dr. Hunt consistently drives transformative growth by aligning cutting-edge technology with customer needs and bringing first-to-market solutions to life. Her leadership philosophy emphasizes collaboration, inclusivity, and excellence, inspiring high-performing teams and cultivating future leaders.
A passionate advocate for environmental sustainability, equity, and corporate responsibility, Dr. Hunt brings a forward-looking perspective to advancing these critical priorities while achieving meaningful business impact. She also contributes her expertise as a Board Director at Veeva Systems, a leader in life sciences cloud software.
Dr. Hunt holds a Ph.D. in environmental engineering from Purdue University and an MBA from the University of Southern Maine, with executive education from Stanford and Harvard Universities.
21. Sai Bhamidipati
Firm: Moderna
Title: Director, Regulatory Affairs CMC
Sai Bhamidipati is an accomplished regulatory affairs professional with extensive experience in the biotechnology industry. As the Director of Regulatory CMC at Moderna. Bhamidipati has led global regulatory strategies for complex novel therapeutics, including mRNA-based therapies, cell and gene therapies, and combination products. Her leadership has been instrumental in ensuring the successful development, submission, and approval of life-changing therapies across multiple markets.
Known for her expertise in navigating regulatory challenges, Bhamidipati is passionate about building robust frameworks that balance innovation with compliance. Beyond her professional achievements, she is deeply committed to mentoring the next generation of leaders and actively contributes to professional organizations such as the Regulatory Affairs Professionals Society (RAPS) and the International Society for Cell and Gene Therapy (ISCT).
22. Leslie Orne
Firm: Trinity Life Sciences
Title: President and CEO
Leslie Orne is the President and CEO and board member of Trinity Life Sciences, and a thought leader to executives in the biopharma industry. She oversees the strategic direction of the company and has been a critical advisor to hundreds of customers across thousands of projects over her more than 20-year tenure. Her support for billions of dollars in strategic transactions and the launches of dozens of products gives Orne a unique vantage point on the industry, and her evidence-forward approach to strategic questions empowers customers to make smart, informed and timely decisions.
As the thirteenth employee to join the company, Orne has played a critical role in growing Trinity to a 1,300 employee-strong organization with 12 global offices servicing 350 active clients. She has spearheaded critical acquisitions for Trinity that have added to the core strategy, insights, and analytics offerings the company has always provided.
These acquisitions included BluePrint Research Group, CBPartners, TGaS Advisors, Bell Canyon and D Cube Analytics, the latter of which dramatically leapfrogged Trinity to become the leading provider of go-to-market analytics and AI to biopharma companies. Orne has also been the architect behind a transformative partnership with Bain & Company that has strategically advanced Trinity’s mission to revolutionize the pharmaceutical commercial model.
Orne has nurtured the careers of rising stars internally as well as at client companies. She was a founding member of the Board of Advisors of Life Science Cares, a collective effort of the life sciences industry to support service organizations that fight poverty in the Greater Boston Area. She also is an avid mentor and advisor to students in the sciences at her alma mater, Dartmouth College.
Leslie graduated from Dartmouth College with a bachelor’s degree in biology.
22. Aparna Deshpande
Firm: Trinity Life Sciences
Title: Senior Partner, Head of Analytics & Insights Ascom
Aparna Deshpande leads the design and execution of primary market research projects in support of Trinity’s consulting engagements. She specializes in shaping therapeutic-area commercial strategy through insights and analytics across multiple disease areas. Deshpande’s focus is on helping clients identify the “right” business questions, developing a hypothesis-based approach to address the question and leveraging her analytical capabilities to identify the most efficient approaches to testing the hypotheses.
With more than a dozen years of domestic and international experience in pharmaceutical market research, Deshpande holds a Ph.D. with a concentration in pharmaceutical market research from the University of Georgia and is a trained pharmacist. She has been an invited speaker to the Federal Drug Administration (FDA), and her quantitative research has been widely published in public policy, health communication, pharmacy education, and pharmacoeconomic journals.
23. Angie Wirick
Firm: AtriCure
Title: Chief Financial Officer
Angela L. Wirick is the Chief Financial Officer of Atricure, where she is responsible for the company’s finance and information technology functions. Immediately prior to this, Wirick served as Vice President of Finance for four years, where she led the global accounting and finance functions of the company and supported strategic initiatives.
Wirick joined the company in 2014 as Director, Finance. Wirick began her career in public accounting at Arthur Andersen and Deloitte & Touche, serving clients in a variety of industries over 14 years. Wirick currently serves on the business advisory council for the School of Business Administration at the University of Dayton. She received her bachelor’s degree in accounting from the University of Dayton and is a certified public accountant (inactive).
24. Candace Wallace
Firm: Relias
Title: Chief Customer Officer
Candace Wallace is the Chief Customer Officer of Relias. She is a dynamic leader dedicated to improving customer relations and empowering employees to achieve excellence. At Relias, a leading provider of workforce enablement solutions for 12,000 healthcare organizations and 4.5 million caregivers, she has driven measurable success through strategic innovation.
Guided by her collaborative and customer-focused approach, Wallace spearheaded the creation of the Customer Excellence Office, a two-year initiative that improved renewal rates by 5 percent, increased net retention by 15 percent year-over-year for scaled customer segments, and enabled more than 20 million annual digital engagements.
Through her commitment to customer success, Wallace has elevated Relias’ efforts to reduce cost and risk, improve retention, and enhance patient care. Her leadership in launching the Voice of Customer program has delivered critical insights that increased net promoter scores by over 50 percent and response rates by 500 percent. Wallace’s strategic vision ensures that Relias’ connected solutions in learning, performance, compliance, quality, and recruiting are aligned with the needs of healthcare organizations and drive improved patient care outcomes nationwide.
25. Karen Dierker
Firm: Capital Rx
Title: Executive Vice President, Enterprise Solutions
Karen Dierker joined Capital Rx as one of its first 10 employees and was a key leader in the development and launch of JUDI in 2021. Currently, she leads the Enterprise Solutions team, accountable for the delivery and service of JUDI as a platform to customers leveraging its SaaS arrangements.
Previously, Dierker served as the SVP of Product Management responsible for expanding upon JUDI’s core capabilities and leading a team of more than 20 product managers and UI/UX designers. In Capital Rx’s nascency, Dierker built and scaled the implementation department from scratch, developing the operating infrastructure to service its growing client base across new business lines while maintaining a 100 percent implementation satisfaction score.
Prior to joining Capital Rx, Dierker spent 13 years in the PBM and healthcare industry at OptumRx, Catamaran, and Walgreens. She led the successful onboarding of large employer groups and health plans. Dierker has also worked for the Walt Disney Company. She holds a bachelor’s degree from the Kelley School of Business at Indiana University and is a certified project management professional (PMP).
26. Dr. Sharon Mates
Firm: Intra-Cellular Therapies
Title: Founder, Chairman, and Chief Executive Officer
Sharon Mates, Ph.D. is an accomplished industry leader with in-depth scientific and business expertise including extensive experience building companies. She has more than 30 years of experience leading public and private companies with a steadfast commitment to cutting-edge science and research to discover innovative approaches to treating disease.
As Founder, Chairman and CEO of Intra-Cellular Therapies (ITCI), Dr. Mates leads the biopharmaceutical company, which is focused on the discovery, clinical development, and commercialization of innovative drugs that address underserved medical needs in complex psychiatric and neurologic diseases.
Dr. Mates has overseen the growth of ITCI from its inception in 2002 to today as a public company which has more than 800 employees, including a national sales force. Prior to co-founding ITCI in 2002, she was President and board member of North American Vaccine Inc. and its predecessor companies for almost a decade, during which time she oversaw the development and approval of pediatric vaccines.
Throughout her career, she has held numerous advisory and board positions including a current board appointment to Biotechnology Innovation Organization (BIO). Previous appointments include chairman of the New York Biotechnology Association, Board of Visitors of the Biotechnology Institute of the University of Maryland, and member of the Harvard School of Public Health Advisory Council of the Center for Society and Health.
Dr. Mates received her bachelor’s degree from The Ohio State University and her Ph.D. from the University of Washington. She completed her postdoctoral fellowships at the Massachusetts General Hospital and Harvard Medical School.
27. Lauren Bennett
Firm: Aeroflow Health
Title: Chief Operating Officer
Lauren Bennett is Chief Operating Officer for Aeroflow Health, where she leads national operational performance and experience. Lauren joined Aeroflow Health in 2014 and has held a variety of leadership roles within the company in strategy, experience, innovation, data analytics and growth. In her current role, Lauren oversees more than 200 operations employees and leaders across multiple business areas at Aeroflow Health. Lauren’s priority is improving the experience for patients, health plans, providers and employees. Previously, Lauren was Vice President of Aeroflow Sleep and Director of Sales Operations for Aeroflow Breastpumps. She is known for driving innovation and efficiency through implementing state-of-the-art automation with a goal of delivering a seamless patient experience.
27. Katie Peng
Firm: Denali Therapeutics
Title: Chief Commercial Officer
Katie Peng is Denali’s Chief Commercial Officer, responsible for building and leading the commercial team that will bring the company’s innovative medicines to patients.
Peng previously served as the Senior Vice President, Head of the OMNI Business Unit at Genentech. She was responsible for the neurology, ophthalmology, immunology, respiratory, and rare diseases portfolio. She spent almost two decades at Genentech and Roche, holding a number of senior leadership positions.
During her tenure, Peng successfully launched multiple products in neurology, oncology, and rare diseases. Between 2012-2017, she was a general manager for Roche in Asia Pacific, leading commercial and medical teams in two countries. Peng has broad U.S. and global experience that spans marketing, sales, market access, medical affairs, and business planning.
Peng began her career as a research scientist at Allergan. After earning her MBA, she joined Amgen, where she held several commercial roles. Peng holds a bachelor’s degree from the University of California, Berkeley and an MBA from the Kelley School of Business, Indiana University.
28. Priti Shah
Firm: Iodine Software
Title: Chief Product and Technology Officer
Priti Shah brings more than 20 years of corporate and product strategy expertise to the Iodine executive leadership team. As Chief Product and Technology Officer, she guides the company’s platform strategy vision while leading its product, engineering, and data science teams. Her leadership focuses on driving innovation, aligning technology initiatives with business objectives, and delivering transformative AI-driven solutions in the healthcare industry.
Before joining Iodine Software, Shah served as Chief Product Officer at Finvi (formerly Ontario Systems), a provider of workflow automation and revenue recovery software. Earlier in her career, she was Vice President of Product and Solutions at Wolters Kluwer Health, where she oversaw the global clinical effectiveness product portfolio, including renowned solutions including UpToDate, Lexicomp, MediSpan, and Emmi. She has also held senior leadership roles in corporate and product strategy at Element K, Skillsoft, and Citrix Systems.
A Harvard Business School alumna of the General Management Program, Shah also holds an MBA in corporate strategy and marketing from the Rochester Institute of Technology and a master’s degree in information systems from the University of Mumbai.
29. Naomi Levinthal
Firm: Reperio Health
Title: Chief Growth Officer
Naomi Levinthal serves as Reperio Health’s Chief Growth Officer. With nearly 20 years of experience as a successful business leader, Levinthal is also a published author and national speaker in medical informatics, digital health, and healthcare IT.
At Reperio Health, Levinthal has responsibility for all commercial and client operations, including sales, marketing, client success, and customer experience. Reperio Health is a preventive care company that is a provider of at-home, comprehensive health screenings with instant results for employers, health plans, hospitals, and individuals. In her tenure, she has launched more than 30 new clients, and helped the company to achieve meteoric growth year-over-year.
Prior to Reperio Health, Levinthal held commercial and strategy leadership positions at Memora Health (acquired by Commure); AVIA Health, and the Advisory Board Company (acquired by Optum). Levinthal holds a master’s degree in health informatics from Northwestern University’s Feinberg School of Medicine and a master’s degree from Loyola University Chicago.
29. Barbara Maglione
Firm: Farmaceutici Damor
Title: R&D Head
Barbara Maglione is Head of R&D at Damor, an Italy-based leading consumer health pharmaceutical company. In 2024, Damor acquired Laboratoires Carilène in France.
Maglione is responsible for leading product research and development, overseeing the entire product lifecycle, and driving forward with delivering customer-focused solutions. In 2020, she contributed to new product and clinical trials development, favoring increase in company revenues. Also critical while navigating COVID-19, she led the team to strengthen bioarginina and fitostimoline product roles in supporting patients during the pandemic.
Prior to Damor, Maglione gained experience in research institutes including Novartis Basel. She holds a master’s degree in molecular biology from University of Milan and completed an executive open marketing program at SDA Bocconi, Milan, Italy. She is certified by AIFA as a qualified person.
30. Julia Chou
Firm: Abridge
Title: Chief Operating Officer
Julia Chou is the Chief Operating Officer at Abridge, an AI company that structures and summarizes medical conversations to unburden clinicians from clerical work, and focuses on what matters most—their patients. Abridge’s science-centered technology platform transforms conversations into structured data and clinical documentation across over 50 specialties, more than 28 languages, and several care settings.
Abridge’s documentation solution is now saving clinicians three hours a day, and its EMR integrated patient-facing summaries are helping people better understand and follow through on their care plans.
Previously, Chou worked at Google before co-founding Binti, focused on making adoption and foster parenting more accessible. Chou graduated from Duke University with a bachelor’s degree in public policy and global health.
31. Jzaneen Lalani
Firm: Nusano
Title: Chief Business Officer
Jzaneen Lalani, or “J-z,” is the Chief Business Officer of Nusano, a physics company reinventing how radioisotopes are produced for healthcare and industry. In this role, she oversees human resources, legal, government affairs, and special projects functions, including the construction of Nusano’s state-of-the-art radioisotope production facility in West Valley City, Utah.
Lalani holds a bachelor’s degree from Queen’s University, a bachelor of law from the University of Victoria, and a master of law in international affairs from Columbia University. To this foundation, she adds more than 20 years’ experience, having managed life sciences companies across a wide variety of functional areas, including as a Chief Operating Officer, and as general counsel at public and privately held companies.
32. Jenn Adams
Firm: August Bioservices
Title: CEO
Jenn Adams is the Chief Executive Officer of August Bioservices, which provides pharmaceutical development and manufacturing services to the biopharmaceutical and biotechnology space, a position she has held since 2020. Prior to her involvement with August Bioservices, she was SVP and President of AmerisourceBergen’s Clinical Product Solutions Business Unit. Ms. Adams spent her early career at Baxter Healthcare, serving in leadership roles in the Medication Delivery and Fenwal businesses. Adams also serves as Senior Advisor to Oak HC/FT, a venture growth-equity fund investing in healthcare information and services.
Adams serves as chair, and a member of the executive committee, for the nonprofit board for LifeScience Tennessee, and also serves as a director on the board of Eton Pharmaceuticals, a publicly traded pharmaceutical company. Adams holds an MBA from Northwestern University’s J.L. Kellogg Graduate School of Management.
33. Dornoosh Zonoobi
Firm: Exo Imaging
Title: VP of AI
Dornoosh Zonoobi is deeply passionate about using technology to reduce healthcare disparities and improve accessibility worldwide. As Vice President of Artificial Intelligence at Exo (pronounced “Echo”) Imaging, she is helping shape the future of medical imaging by integrating innovative AI with Exo’s high-performance handheld ultrasound platform. Exo’s mission to modernize healthcare reflects her commitment to harnessing technology for meaningful impact.
Before joining Exo, Zonoobi founded and served as CEO of Medo.ai, a health-tech startup dedicated to making ultrasound more accessible through advanced AI solutions. Medo launched two FDA-cleared products and grew from a bold idea to an acquisition by Exo, leaving a lasting mark on the industry.
Zonoobi holds a Ph.D. in computer vision and machine learning from the National University of Singapore and completed her post-doctoral fellowship in 3D ultrasound analysis at the University of Alberta’s Radiology Department. With a deep sense of purpose and a collaborative spirit, Zonoobi continues to advocate for the use of AI and technology to create a more equitable and inclusive healthcare system, touching lives one innovation at a time.
33. Karen Luk
Firm: Cylinder Health
Title: Chief Product Officer
Karen Luk is the Chief Product Officer of Cylinder Health. Founded in 2021 and offered as an employer benefit, Cylinder (formerly Vivante Health) delivers personalized, clinician-backed care to those suffering from digestive issues through its virtual health platform. With more than 20 years of product management experience, Luk has focused on health care products and services for nearly a decade.
Before joining Cylinder, her work focused on mental health, driving the member experience as Vice President of Product at AbleTo. Luk has held product leadership roles across several health tech companies focused on electronic health records, patient engagement, care management software, and COVID-19 response in public health. Luk graduated from the University of Waterloo with an undergraduate degree in biochemistry and business.
34. Michelle Teh
Firm: Nice Healthcare
Title: VP of Technology
Michelle Teh is the VP of Technology at Nice Healthcare, where she thrives on transforming chaos into structured success. Teh effortlessly cuts through the noise, fosters collaboration across disciplines, and inspires a pursuit of innovative, technical solutions that enhance everyday life.
In her role, Teh continues to elevate the technology platform prioritizing the clinician’s perspective and patient care, while ensuring smooth operations, positive user experiences, and overall efficiency.
35. Kathy Dalton Ford
Firm: Trella Health
Title: Chief Product Officer
As Chief Product Officer, Kathy Ford spearheads Trella Health’s product development initiatives, shaping the strategic vision and execution with her extensive experience in healthcare technology leadership. Trella Health’s unmatched market intelligence and purpose-built CRM allow post-acute providers, HME, and infusion organizations to drive more effective performance and growth and to identify the highest-potential referral targets, evaluate new market opportunities, and monitor performance metrics.
With more than three decades of experience, Ford has been a driving force in healthcare technology innovation. She has led the commercialization of numerous clinically impactful solutions across the care continuum.
Prior to her role at Trella Health, Ford served as Chief Product and Strategy Officer at Project Ronin, driving exponential growth. Before that, she held the position of President and Chief Product Officer at Rhinogram. Ford also co-founded Jellyfish Health, pioneering advancements in patient flow logistics. Earlier in her career, she oversaw executive-level portfolios, guided merger and acquisition activities, and led product efforts at GE Healthcare, Siemens Medical, McKesson, and NantHealth.
36. Katie Eggers
Firm: KarmaCheck
Title: Vice President, Head of Delivery and Customer Experience
Katie Eggers is the architect of KarmaCheck’s customer experience. Her strategic vision is a cornerstone of KarmaCheck’s trailblazing offering: reducing friction in the healthcare job market by reimagining background checks and digital identity solutions for nurses and clinicians.
Eggers has driven transformative initiatives across multiple industries, with a rich background that includes tenures at Code for America and BlackRock. She scaled groundbreaking tax preparation software that simplified the tax refund process for the country’s most vulnerable, launched one of the first actively-managed bond ETFs, and managed multi-sector investments for institutional clients across an $80 billion business.
Beyond her corporate achievements, Eggers’ commitment to education shines, as highlighted by her time as an instructor at the University of Denver and her role in a Stanford University initiative to kickstart digital education for Title 1 high schools. As an instructor, she taught topics including financial analysis, programming, machine learning, and blockchain.
With a bachelor of commerce degree in finance and economics, Katie’s dedication to excellence is further reflected in a graduate certificate in computer science, and additional certifications in Lean Six Sigma, product management, and project management.
37. Mary Ryan
Firm: Penlon Limited
Title: Director Of Innovation, Technology & Regulatory Affairs
Mary Ryan, Director of Innovation, Technology and Regulatory Affairs at Penlon Limited, is a multi-award-winning Medical Device Quality and Regulatory Professional who spearheaded the Development and Regulatory approvals for the NHS Ventilator Challenge (VCUK), showcasing her leadership in times of national critical need during the pandemic. Mary was responsible for overseeing the design, development, certification and cross-industry involvement including a consortium of Formula 1, Aerospace and Automotive technologies in the manufacturing thousands of ventilators for the UK NHS in response to the urgent need for life-saving medical devices.
Mary is a distinguished professional in the medical device sector, renowned for her expertise in Quality Assurance and Regulatory Affairs (QARA). A seasoned Executive with a career spanning nearly three decades, Mary has become an influential force in shaping the landscape of medical technology and regulatory frameworks on a global scale and has hand-held many device companies in bringing their products to market.
Mary’s professional journey began in the technical fields of plastic injection moulding and electronics manufacturing, evolving into a distinguished trajectory of leadership and innovation in the medical device sector. She has headed a UK Notified Body, driving impactful changes in global medical device regulations, and has led transformative projects across healthcare technology. As a trusted collaborator with various Government Ministries of Health, Mary has helped shape policy and legislation in the UK, Kingdom of Saudi Arabia and across the Middle East. A lifelong advocate for advancing healthcare technology, Mary is dedicated to supporting innovators, medical device manufacturers, and government bodies in delivering essential medical devices to patients worldwide, transcending geopolitical and circumstantial barriers. Mary holds a Bachelor of Science degree from Heriot-Watt University in Edinburgh and is an active participant and industry representative at the Association of British Healthcare Industries (ABHI).
Beyond her professional accomplishments, Mary is dedicated to making a meaningful difference in her community. She volunteers with young people with special needs, mentors women in recovery, and actively contributes to the Impactful Founders Club, a network of changemakers committed to amplifying their impact and driving positive global change.
Founded in 1943, Penlon Limited has been at the forefront of medical innovation for over 80 years, setting the standard in anaesthesia and oxygen therapy. As a proud UK-based leader in medical equipment, Penlon combines cutting-edge technology with exceptional quality to deliver life-saving solutions to healthcare providers and patients worldwide. With a strong presence in over 90 countries, Penlon’s commitment to excellence and compliance has earned the trust of medical professionals across the globe. Through continuous research, development, and collaboration, the company remains dedicated to advancing healthcare, enhancing patient safety, and shaping the future of anaesthesia.
38. Dr. Ewa Kleczyk
Firm: Target RWE
Title: SVP, Commercial Analytics & Data Curation
Dr. Ewa J. Kleczyk is a distinguished leader in healthcare analytics, serving as the Senior Vice President of Commercial Analytics and Data Curation at Target RWE. With expertise in enhancing data quality and validation frameworks, she drives the delivery of actionable insights, empowering pharmaceutical, biotech, and healthcare organizations to address critical needs for patients and caregivers.
With two decades of experience, Dr. Kleczyk is celebrated as a pioneer in healthcare analytics and technology. She is a sought-after speaker at prominent industry conferences, including the Pharmaceutical Management Science Association (PMSA), LOSD at Harvard University, and Chief Data and Analytics Office Exchange. Her thought leadership spans scholarly journals, academic publications, community podcasts, and live-streamed events. Committed to fostering the next generation of talent, Dr. Kleczyk mentors aspiring data analysts, with a particular focus on empowering women to achieve leadership roles.
Beyond her professional achievements, Dr. Kleczyk is an active community advocate, serving as a Board Member of the Community Cancer Council for the Northern Light Health Network in Bangor, Maine. Together with her husband, she supports graduate students at the University of Maine through the Kleczyk/Strout Family Scholarship.
Dr. Kelczyk has been previously recognized by the Healthcare Technology Report as one of Pennsylvania’s Top 25 Technology Leaders and one of the Top 25 Women in Biotechnology for 2023. She earned her doctorate in economics from Virginia Tech.
39. Leah Ray
Firm: Linus Health
Title: Chief Customer and Administrative Officer
Leah Ray is the Chief Customer Officer and Chief Administrative Officer at Linus Health, where she is responsible for all post-sales activities including implementation, customer success, customer support, people operations and legal. Ray brings more than 25 years of customer-facing experience in the Healthcare IT products and services industry.
Prior to joining Linus Health, Ray served as Chief Customer Officer at Jvion, the industry leader in clinical artificial intelligence. Before Jvion, Ray held the position of SVP Customer Experience at Zelis and Chief Customer Experience officer at Healthx. During Ray’s robust career she has held senior executive leadership roles within customer experience, product management, and data integration at a host of healthcare SaaS organizations.
Ray attended Kennesaw State University, holds certifications in product management and project management, and has a professional academy for healthcare management designation.
40. Shelly Bond
Firm: Ascom
Title: Vice President of Sales and Business Development
Shelly Bond is a distinguished sales leader with more than 30 years of experience driving success in the healthcare technology sector. As the Vice President of Sales and Business Development for Canada at Ascom Americas, Bond has played a pivotal role in accelerating the company’s growth, expanding its market footprint, and shaping its strategic direction since September 2019.
Under her leadership, Ascom’s business in Canada has surged by an impressive 304 percent. Her exceptional track record of exceeding sales targets is a testament to her expertise, with annual quota achievements consistently surpassing 115 percent, including an outstanding 123 percent in 2023 and 131 percent in 2024.
In her current role, Bond leads a high-performing sales team while managing a diverse portfolio of channel partners and direct market engagements. She leverages Ascom’s cutting-edge healthcare platform to deliver Smart Workflows that enable real-time patient data access, early warning scoring, and actionable alerts, transforming healthcare delivery across Canada.
Bond’s strategic mindset and profound understanding of the healthcare landscape have been instrumental in advancing Ascom’s comprehensive suite of solutions, including nurse call and emergency call systems, medical device integration, and middleware solutions. Driven by a passion for improving patient outcomes and operational efficiencies, she is a strong advocate for the quadruple aim in healthcare.
Before joining Ascom, Bond excelled as the Senior Area Sales Manager for Eastern Canada at Vocera Communications (now part of Stryker), where her consultative sales approach led to transformative partnerships with prestigious institutions, including the Niagara Health System, Sunnybrook Health Sciences Centre, and the University of Ottawa Heart Institute. Her career in healthcare began at St. Joseph’s Healthcare, where she served as a business consultant and program manager, gaining a deep foundation in the industry’s needs and challenges.
Throughout her career, Bond has demonstrated unparalleled expertise in account management, sales strategy, and systems development, cultivating strong relationships with key stakeholders and driving innovative healthcare solutions. A highly respected leader, she is committed to both personal and professional growth.
She holds a degree in economics from the University of Waterloo, a diploma in marketing management from Humber College, and certifications in project management and senior leadership from the University of Toronto. Most recently, she earned a certificate in the soul of leadership and well-being from Deepak Chopra.
40. Robin Ntoh
Firm: Nextech Systems
Title: Vice President of Aesthetics
Robin Ntoh is the Vice President of Aesthetics of Nextech Systems. Nextech is a complete healthcare technology solution for specialty providers. Since 1997, Nextech has been focused on delivering innovative solutions and services that drive efficiency, fuel growth, and enhance the patient care experience.
A recognized expert in the business of elective healthcare and aesthetics, Ntoh has seen success in the launch of both her own consulting company and the addition of consulting services for Nextech,serving more than 400 clients. Her more than 34 years of experience include small-mid business management as well as executive leadership for one of the leading Aesthetic HCPs, Nextech.
Ntoh graduated from Palm Beach Atlantic University with an undergraduate degree in biochemistry and molecular biology.
41. Noga Leviner
Firm: PicnicHealth
Title: Co-Founder and CEO
Noga Leviner is the Co-Founder and CEO of PicnicHealth, a health technology company dedicated to simplifying healthcare for both patients and researchers.
When Leviner was diagnosed with Crohn’s disease, she was surprised there wasn’t one single doctor or system that would help manage her disease and share her health data across providers. She co-founded PicnicHealth to eliminate this burden and give every patient complete access to their medical records, while also simplifying observational research for life sciences companies.
To date, the company’s direct-to-patient approach and innovative AI and technology platform have enabled 12 of the top 20 largest life science companies to run more efficient observational research. PicnicHealth has given tens of thousands of patients access to tools and virtual care services to simplify their care journey.
Leviner is a vocal advocate for patient data access in the U.S. healthcare system and has spoken widely on the subject, including at the White House. Noga holds a bachelor’s degree in human biology and economics from Stanford University.
42. Dr. Nogah Shabshin
Firm: Nanox Imaging
Title: Medical Director of ARC division
Dr. Nogah Shabshin is a distinguished musculoskeletal radiologist and the Medical Director of the ARC division at Nanox Imaging. With more than two decades of experience in clinical practice, academic research, and biomedical consulting for multiple companies, she has made significant contributions to the advancement of medical devices, radiology and healthcare technology.
As the Medical Director of the ARC division at Nanox, Dr. Shabshin plays a key role in shaping the clinical strategy for Nanox.ARC, focusing on developing innovation, clinical and economic claims (user experience). She is also part of the regulatory efforts that led to the FDA approval.
Her responsibilities include guidance of the R&D and clinical team in innovation of future developments, improvement and implementation of existing features, establishing collaborations for the ARC, engaging with potential clinical trial sites to define protocols that maximize the collaboration’s potential, and analyzing incoming data to support claim validation.
Dr. Shabshin has held leadership roles at renowned medical institutions, including Penn Medicine and Clalit Health Services, and served as Chair of Radiology at Assuta Medical Centers in Israel. She has published more than 60 scientific articles and delivered over 170 invited lectures and scientific presentations.
In addition to her clinical and academic work, Dr. Shabshin has held editorial roles at the medical journal, Skeletal Radiology, and has been actively involved in professional societies, including the International Skeletal Society, where she has chaired and is a member of several committees.
Dr. Shabshin earned her MD and bachelor’s degree from the Technion, Israeli Institute of Technology and her MBA from the Kellogg-Recanati Executive MBA program.
43. Aleeza Hashmi Shafi
Firm: Dentive
Title: VP, Growth & Operations
Aleeza Hashmi Shafi is the VP of Growth and Operations at Dentive. Dentive is a partnership-focused Dental Partner Organization (DPO) based in Provo, Utah. Its unique model centers on collaborating with top dentists, oral surgeons, and orthodontists across the country while providing expert-level business support. Hashmi has 12 years of experience. She began her career in 2013.
Prior to working in the dental industry, Shafi was an investor at Bessemer Venture Partners’ Silicon Valley office, where she supported top founders focused on enterprise SaaS, vertical SaaS, and healthcare. Before joining Bessemer, she studied at Wharton, dedicating much of her time to working with pre-seed and seed-stage founders through Rough Draft Ventures and General Catalyst. She gained operational experience at Microsoft, working alongside a team known for exemplifying a strong growth mindset.
Shafi graduated from The Wharton School with an MBA and from Harvard University with an undergraduate degree in history and sciences.
44. Cerys Goodall
Firm: Vetster
Title: Chief Operating Officer
Cerys Goodall is the Chief Operating Officer at Vetster, the world’s largest pet telehealth platform. An advocate for women in tech with a focus on pay equity, Goodall, who joined the company in 2021, leads growth and operations at Vetster, bringing more than 20 years of experience dedicated to building the brands of early stage and high-growth startups including LEAGUE, Kobo and InnerSpace.io. Under Goodall’s leadership, her teams are responsible for expanding Vetster’s marketshare, building a world-class pet health brand, and scaling its operations internationally. The company serves millions of pet owners in more than 50 countries.
44. Anna Graziano
Firm: DeepScribe
Title: Head of Customer Success
Anna Graziano brings over a decade of experience in healthcare to her role as Head of Customer Success at DeepScribe. Since joining in September 2022, Graziano and her team have set the bar for adoption in healthcare’s ambient AI marketplace. Under her leadership, DeepScribe achieved the industry’s highest KLAS Research rating of 98.8 in 2024 and established strategic partnerships with leading healthcare institutions including Texas Oncology and Ochsner Health.
Drawing from her experience as a builder in health tech, Graziano brought this innovative mindset to Privia Health, where she pioneered comprehensive scribe, coding, and billing services and also established the company’s first EHR training program. During her tenure, Privia Health held its IPO in 2021.
Graziano’s approach to customer success is rooted in a deep understanding of healthcare providers’ needs and a commitment to building lasting relationships. She believes technology can transform the human side of healthcare delivery and she puts this conviction into practice by advocating for removing barriers for clinicians in all aspects of her work. This philosophy shapes her leadership style and contributes to DeepScribe’s success.
Currently pursuing her MBA at the University of Minnesota’s Carlson School of Management, Graziano holds an economics degree from Macalester College, where she also studied music. She remains connected to her alma mater through the college’s entrepreneurship program, serving as a mentor and judge for their annual hackathon, helping to nurture the next generation of healthcare innovators.
45. Joy Somogyi
Firm: Atropos Health
Title: SVP Marketing
Joy Somogyi joined Atropos Health, a pioneer in translating clinical real-world data into personalized real-world evidence (RWE) and insights, as the Senior Vice President of Marketing in October 2023 and is focused on building a community devoted to making evidence the basis for decision making in medicine.
Her marketing skills contributed to the company’s $33 million Series B funding in 2024. She also led the launch of ChatRWD, a chat-based AI co-pilot for clinicians and researchers that reduces the time to produce high-quality, publication-grade RWE from months to minutes.
Somogyi is passionate about building brands with storytelling and has successfully launched industry changing technologies that achieve the quadruple aim in healthcare throughout her career. Prior to joining Atropos Health, she was leading marketing for a pre-seed stage AI-driven patient platform start-up.
Somogyi has held various leadership roles in marketing, including Head of Product Marketing at Omnicell, a robotics and medical device company, where she launched their first SaaS product OmnicellOne. Somogyi also spent several years at athenahealth, Philips and AmWell building and managing marketing teams, and earned dual bachelor’s degrees from Brown University and a master’s degree in communication from Boston University.
46. Meena Mallipeddi
Firm: AmplifyMD
Title: Co-Founder and CEO
Meena Mallipeddi is a successful executive and entrepreneur with years of experience working at the intersection of healthcare, technology, and finance. After a rewarding tenure on the business side of healthcare, Mallipeddi co-founded AmplifyMD to address significant needs (both medical and financial) for specialty access in hospitals and outpatient
settings across the country.
Since 2019, her team has developed a groundbreaking virtual care efficiency platform that seamlessly integrates with EHRs and other medical technologies, making virtual care faster, easier, and more cost-effective. Today, Mallipeddi is expanding the impact of AmplifyMD, building a network of partner practices, medical facilities, and other healthcare entities to bring specialty care where it’s needed, when it’s needed.
Mallipeddi received her bachelor’s degree from Stanford University and master’s degree in technology from University of Cambridge. She currently serves on the American Telemedicine Association’s Leadership Council.
47. Sharmeen Roy
Firm: DoseMe
Title: Chief Science and Strategy Officer
Sharmeen Roy is the Chief Science and Strategy Officer of DoseMe. Her 20-year career spans pediatric clinical pharmacy, clinical research, pharmacogenomics, and strategic leadership. She received her doctor of pharmacy degree from the University of Illinois at Chicago and completed a pediatric specialty pharmacotherapy residency at Texas Children’s Hospital.
Roy is board certified in pharmacotherapy and holds a certification in pharmacogenomics from University of Florida. Her tenure includes esteemed institutions such as Texas Children’s Hospital, University of Chicago Medical Center, Nicklaus Children’s Hospital, and Miami Cancer Institute.
At PipelineRx, she held senior roles, managing large teams and driving client engagement for over 500 hospitals. She is actively involved in CPIC, STRIPE, PIDS, ACCP, ASHP and PPA. Being a practitioner who embraces technology, Roy strategically blends her extensive clinical expertise with cutting-edge innovations, leading the way in enhancing patient care.
48. Dr. Hala Borno
Firm: Trial Library
Title: Chief Executive Officer
Hala Borno, MD is a physician scientist, Associate Professor of Medicine at the University of California San Francisco, Founder, and Chief Executive Officer of Trial Library, an AI-enabled research platform with a mission to advance access to cancer precision medicine. Dr. Borno has published over 100 peer-reviewed papers and previously served as co-Medical Director of the Genitourinary Medical Oncology Clinic at the Helen Diller Family Comprehensive Cancer Center (HDFCCC) at UCSF.
At HDFCCC, Dr. Borno served on the executive leadership committee for the Prostate Cancer Program and the Liaison to the Office of Community Engagement. She has also served as a member of the American Society of Clinical Oncology Social Determinants of Health working group, and GU committee for NRG oncology. She previously served as the Vice Chair of the Health Disparities Committee for Alliance for Clinical Trials in Oncology.
Dr. Borno graduated with honors in biochemistry and received her medical degree from the University of North Carolina at Chapel Hill. She completed her internal medicine residency and medical oncology fellowship training at UCSF. She served as chief oncology fellow at UCSF and was a National Institute on Aging T32 research fellow in the Division of Geriatrics. Dr. Borno’s research has been featured in peer-reviewed journals including JAMA Oncology, Cancer, and Nature. Her work has been covered by national news outlets.
49. Carrie Haverty
Firm: Mirvie
Title: Vice President, Product
Carrie Haverty leads Mirvie’s efforts to develop the proprietary Mirvie RNA platform. The platform is first to predict unexpected complications months before symptoms occur by revealing the underlying biology of each pregnancy. It opens a new window into pregnancy health for women to act and their doctors to intervene before unexpected complications become a crisis. Mirvie is shaping the future of pregnancy health by enabling proactive, preventive, and personalized pregnancy care for the well-being of moms and babies.
As a board-certified genetic counselor, Haverty’s direct patient care focused on high-risk prenatal care and providing broad access to new diagnostic technologies. She led clinical teams at Massachusetts General Hospital and Sutter Health.
Her direct-clinical experience served as the foundation for leading-edge product development at Counsyl, Myriad, and Miroculus.
50. Crystal Muilenberg
Firm: Acorn Biolabs
Title: Chief Commercial Office
Crystal Muilenburg is a seasoned leader in healthcare technology, specializing in aesthetics and regenerative medicine. As Chief Commercial Officer at Acorn Biolabs, she is leading the launch of the company’s innovative secretome product, a topical derived from preserved live cells, through its early access program.
With nearly 25 years of experience, Muilenburg has held key roles at companies including Evolus, Sienna Biopharmaceuticals, and Allergan. At Evolus, she re-launched Jeuveau, which became the fastest-growing neurotoxin in the U.S. and one of the top product launches in aesthetics history. Earlier, at Allergan, she contributed to the commercial success of BOTOX and other major aesthetics brands.
Known for her strategic insight and ability to bring cutting edge innovations to market, Muilenburg continues to drive advancements in personalized medicine and transformative healthcare solutions.
50. Dr. Isabel Fulcher
Firm: Delfina
Title: Chief Scientific Officer
Dr. Isabel Fulcher is a statistician dedicated to enhancing reproductive healthcare through data science and digital health technologies. As Chief Scientific Officer and Co-Founder at Delfina, she integrates diverse data sources and advanced analytical tools to develop patient-centered technologies that improve pregnancy care.
Dr. Fulcher earned her Ph.D. in Biostatistics from Harvard University, where her thesis focused on developing novel statistical methods to estimate causal effects in complex data settings. She subsequently served as a postdoctoral fellow at the Harvard Data Science Initiative, specializing in integrating causal inference methods into implementation science to evaluate the impact of programs and policies on health outcomes. During this time, she collaborated with organizations including Planned Parenthood, Partners In Health, D-tree International, and Mass General Brigham.
